Search Results - "Good, William"

Retinopathy of Prematurity Incidence in Children by Good, William V.

Get full text

Alan B. Scott, MD by Good, William V.

Get full text

Ethics in the editorial process by Good, William V.

Get full text

Screening Examination of Premature Infants for Retinopathy of Prematurity by Fierson, Walter M

“…This policy statement revises a previous statement on screening of preterm infants for retinopathy of prematurity (ROP) that was published in 2013. ROP is a…”
Get full text

Ocular neovascularization following hypoxic ischemic encephalopathy by Loveridge-Easther, Cam, Good, William V.

“…We present the findings of 2 children with neonatal hypoxic ischemic encephalopathy (HIE), who demonstrated ocular neovascularization at birth. While the…”
Get full text

Genetic Variants of the Beta-Adrenergic Receptor Pathways as Both Risk and Protective Factors for Retinopathy of Prematurity by Paradis, Hélène, Werdyani, Salem, Zhai, Guangju, Gendron, Robert L., Tabrizchi, Reza, McGovern, Margaret, Jumper, J. Michael, Brinton, Daniel, Good, William V.

“…There is strong evidence that genetic factors influence retinopathy of prematurity (ROP), a neovascular eye disease. It has been previously suggested that…”
Get full text

Vision Screening in Very Young Children-Making Sense of an Inexorable Diagnostic Process by Good, William V

Get more information

Bevacizumab for Retinopathy of Prematurity: Treatment When Pathology Is Embedded in a Normally Developing Vascular System by Good, William V., MD

Get full text

Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity by Wallace, David K, Kraker, Raymond T, Freedman, Sharon F, Crouch, Eric R, Bhatt, Amit R, Hartnett, M Elizabeth, Yang, Michael B, Rogers, David L, Hutchinson, Amy K, VanderVeen, Deborah K, Haider, Kathryn M, Siatkowski, R Michael, Dean, Trevano W, Beck, Roy W, Repka, Michael X, Smith, Lois E, Good, William V, Kong, Lingkun, Cotter, Susan A, Holmes, Jonathan M

“…Intravitreous bevacizumab (0.25 mg to 0.625 mg) is commonly used to treat type 1 retinopathy of prematurity (ROP), but there are concerns about systemic…”
Get more information

The impact of early exposure to general anesthesia on visual and neurocognitive development by Wong-Kee-You, Audrey M.B., Loveridge-Easther, Cam, Mueller, Claudia, Simon, Noah, Good, William V.

“…Every year millions of children are exposed to general anesthesia while undergoing surgical and diagnostic procedures. In the field of ophthalmology, 44,000…”
Get full text

J AAPOS has a new look by Good, William V.

Get full text

Screening Examination of Premature Infants for Retinopathy of Prematurity by Fierson, Walter M

“…This statement revises a previous statement on screening of preterm infants for retinopathy of prematurity (ROP) that was published in 2006. ROP is a…”
Get full text

Bilirubin-induced neurotoxicity and visuocortical dysfunction by Good, William V., Wong, Ronald J., Norcia, Anthony M., Stevenson, David K., Slagel, Terri, Hou, Chuan, Bhutani, Vinod K.

Get full text

Detection of Amblyopia Using Sweep VEP Vernier and Grating Acuity by Hou, Chuan, Good, William V, Norcia, Anthony M

“…Vernier and grating acuity can be measured with swept-parameter visual evoked potentials (sVEP). However, whether sVEP Vernier and grating acuities are…”
Get full text

Association of Vaccinations in Young Children and Retinal Hemorrhages by Good, William V

Get more information

Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study by Wallace, David K, Kraker, Raymond T, Freedman, Sharon F, Crouch, Eric R, Hutchinson, Amy K, Bhatt, Amit R, Rogers, David L, Yang, Michael B, Haider, Kathryn M, VanderVeen, Deborah K, Siatkowski, R Michael, Dean, Trevano W, Beck, Roy W, Repka, Michael X, Smith, Lois E, Good, William V, Hartnett, Mary Elizabeth, Kong, Lingkun, Holmes, Jonathan M

“…Intravitreous bevacizumab (0.25 to 0.625 mg) is increasingly used to treat type 1 retinopathy of prematurity (ROP), but there remain concerns about systemic…”
Get more information

Vision testing in cortical visual impairment: ocular motor confounders by Brodsky, Michael C., Good, William V.

Get full text

Robert Jackson Hardy, PhD by Palmer, Earl A., Good, William V.

Get full text

Arthur Jampolsky, MD by Good, William V., The Jampolsky Family, Brabyn, John

Get full text

Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity Study: Findings at 4 to 6 years of age by Quinn, Graham E., MD, MSCE, Dobson, Velma, PhD, Davitt, Bradley V., MD, Wallace, David K., MD, MPH, Hardy, Robert J., PhD, Tung, Betty, MS, Lai, Dejian, PhD, Good, William V., MD

“…Purpose To report the prevalence of myopia and high myopia in children <6 years of age born preterm with birth weights <1251 g who developed high-risk…”
Get full text